BridgeBio Pharma, Inc.【BBIO】 業績推移・財務諸表

(単位:千ドル) 2Q19 3Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 - 26,741 - - 8,127 462 54,024 2,344 1,694 73,746 338 1,826 1,641 4,091 211,120 2,168 2,732 116,633
売上成長率(%) - - - - - - 1110.36 11461.88 32.11 -33.22 -44.76
売上原価 - - - - - - 109 1,454 - - - - 599 598 598 598 598 2,639
研究開発費 - 55,278 68,225 86,598 92,050 122,559 101,960 104,305 107,649 108,400 92,511 92,861 107,488 125,136 140,972 114,695 120,444 111,431
販売管理費 - - - - - - 45,970 46,084 43,713 36,426 31,188 31,108 36,122 35,777 65,807 59,523 68,819 106,365
営業費用 69 81,273 102,487 124,567 128,066 167,966 148,039 151,843 175,372 153,922 129,454 127,989 147,740 161,783 210,777 177,707 194,482 221,005
営業利益 - -54,532 -102,487 -124,567 -119,939 -167,504 -94,015 -149,499 -173,678 -80,176 -129,116 -126,163 -146,099 -157,692 343 -175,539 -191,750 -104,372
営業利益率 (%) - - - -3854.61 0.16 -8096.82 -7018.67 -89.49
純利益 - -60,664 -104,082 -136,214 -130,167 -171,082 -102,074 -161,016 -201,330 -2,559 -140,193 -142,732 -160,703 -179,488 -36,160 -75,544 -164,254 -169,608
純利益率(%) - - - -4387.39 -17.13 -3484.5 -6012.23 -145.42
一株あたり利益 - - - - - - - - - -0.07 -0.93 -0.92 -0.98 -1.08 -0.2 -0.39 -0.86 -0.88
希薄化後一株あたり利益 - - - - - - - - - -0.07 -0.93 -0.92 -0.98 -1.08 -0.2 -0.39 -0.86 -0.88
EBITDA - - - - - - - - - - - - 1,939 - - -
EBITDAマージン(%) - - - - - - - - - - - - 0.92 - - -